Last update 23 Mar 2026

Selective ARID1B(Foghorn Therapeutics)

Overview

Basic Info

Drug Type
Proteolysis-targeting chimeras (PROTAC)
Synonyms
First in class selective ARID1B degraders(Foghorn Therapeutics)
Target
ARID1B
Action
degraders
Mechanism
ARID1B degraders(AT-rich interaction domain 1B degraders)
Therapeutic Areas
NeoplasmsDigestive System DisordersEndocrinology and Metabolic Disease+ [1]
Active Indication
Endometrial CarcinomaOvarian CancerStomach Cancer
Inactive Indication-
Originator Organization
Foghorn Therapeutics, Inc.Foghorn Therapeutics, Inc.
Active Organization
Foghorn Therapeutics, Inc.Foghorn Therapeutics, Inc.
Inactive Organization-
License Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with Selective ARID1B(Foghorn Therapeutics)
Login to view more data
100 Translational Medicine associated with Selective ARID1B(Foghorn Therapeutics)
Login to view more data
100 Patents (Medical) associated with Selective ARID1B(Foghorn Therapeutics)
Login to view more data
100 Deals associated with Selective ARID1B(Foghorn Therapeutics)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Endometrial CarcinomaPreclinical
United States
Foghorn Therapeutics, Inc.Foghorn Therapeutics, Inc.
21 Apr 2026
Ovarian CancerPreclinical
United States
Foghorn Therapeutics, Inc.Foghorn Therapeutics, Inc.
21 Apr 2026
Stomach CancerPreclinical
United States
Foghorn Therapeutics, Inc.Foghorn Therapeutics, Inc.
21 Apr 2026
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free